» Articles » PMID: 36978496

: A Challenging Cause of Protracted Tenosynovitis

Overview
Specialty Pharmacology
Date 2023 Mar 29
PMID 36978496
Authors
Affiliations
Soon will be listed here.
Abstract

infections are rare, and they can be difficult to diagnose and treat. This may lead to further spread of the infection and complications, such as tenosynovitis, pyomyositis, and osteomyelitis. A 40-year-old previously healthy man presented with tenosynovitis of the extensor tendons on the second phalanx of his right hand. He was initially treated with steroid injections without any effect. Followingly, ulceration and an abscess developed on the dorsal site of the hand. At this point, it came to the physician's knowledge that the patient had been cleaning an aquarium before onset of symptoms. After progression to massive tenosynovitis, the patient was admitted and underwent multiple surgical debridements. Briefly, after the first surgery, an interferon-γ release assay was positive, and treatment for with rifampicin and azithromycin was initiated after eight months of symptoms. Later, a surgical biopsy showed acid-fast bacilli, and a polymerase chain reaction confirmed the diagnosis of . In this case story, we highlight the difficulties of diagnosing and managing this complicated infection, describe the considerable morbidity associated with it, and suggest that local tissue concentrations could be useful to improve clinical outcomes, as these concentrations are potentially suboptimal.

Citing Articles

: A Case-Based Narrative Review of Diagnosis and Management.

Tsiolakkis G, Liontos A, Filippas-Ntekouan S, Matzaras R, Theodorou E, Vardas M Microorganisms. 2023; 11(7).

PMID: 37512971 PMC: 10384600. DOI: 10.3390/microorganisms11071799.

References
1.
Piersimoni C, Scarparo C . Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis. 2009; 15(9):1351-8. PMC: 2819852. DOI: 10.3201/eid1509.081259. View

2.
Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

3.
Holden I, Kehrer M, Andersen A, Wejse C, Svensson E, Johansen I . Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome. Sci Rep. 2018; 8(1):6738. PMC: 5928249. DOI: 10.1038/s41598-018-24702-7. View

4.
Alsultan A, Peloquin C . Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs. 2014; 74(8):839-54. DOI: 10.1007/s40265-014-0222-8. View

5.
JERNIGAN J, Farr B . Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Infect Dis. 2000; 31(2):439-43. DOI: 10.1086/313972. View